RVC Medical IT has been acquired by NEXUS AG
September 2020 — Main Capital Partners B.V. has sold RVC Medical IT B.V. to NEXUS AG.
RVC Medical IT is an innovative independent software vendor offering a comprehensive healthcare enterprise imaging software suite. RVC’s product range comprises specialized front-end client software for diagnostic workstations of radiology and all medical specialties outside radiology, complemented with a vendor neutral archive (VNA), RVC clinical repository, which can store all types of images (DICOM and Non-DICOM), documents, data and signals. Notable customers include Isala, UMC Utrecht, Tergooi, Kliniken des Landeskreises Lörrach and UZ Gent. The company is headquartered in Amersfoort, the Netherlands and employs more than 70 people. It has a market share of around 53% and a customer base of 41 hospitals.
Headquartered in Germany and with over 1,300 employees, NEXUS is a leading European healthcare software company and provider of hospital and diagnostic information systems.
Main Capital is a strategic investor with an exclusive focus on the software sector in the Benelux, DACH and Nordics regions. The firm has a long-term strategy of forming successful partnerships with management teams, with the aim of building larger software groups together. Main Capital has over US$1 billion in assets under management for investments in mature and growing software companies.
Our role in the transaction
Oaklins’ team in the Netherlands advised the shareholders of RVC Medical IT.
Talk to the deal team
Frederik van der Schoot
Oaklins Netherlands
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Learn more